nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethinyl Estradiol—ESR1—ovarian cancer	0.251	0.702	CbGaD
Ethinyl Estradiol—NR1I2—Paclitaxel—ovarian cancer	0.119	0.269	CbGbCtD
Ethinyl Estradiol—ABCB1—ovarian cancer	0.106	0.298	CbGaD
Ethinyl Estradiol—NR1I2—Docetaxel—ovarian cancer	0.0862	0.195	CbGbCtD
Ethinyl Estradiol—ABCB11—Paclitaxel—ovarian cancer	0.0455	0.103	CbGbCtD
Ethinyl Estradiol—ABCB11—Doxorubicin—ovarian cancer	0.0245	0.0554	CbGbCtD
Ethinyl Estradiol—ABCC2—Paclitaxel—ovarian cancer	0.0239	0.054	CbGbCtD
Ethinyl Estradiol—ABCC2—Carboplatin—ovarian cancer	0.0225	0.0508	CbGbCtD
Ethinyl Estradiol—ABCC2—Docetaxel—ovarian cancer	0.0173	0.039	CbGbCtD
Ethinyl Estradiol—ABCB1—Topotecan—ovarian cancer	0.0158	0.0356	CbGbCtD
Ethinyl Estradiol—ABCC2—Doxorubicin—ovarian cancer	0.0129	0.0291	CbGbCtD
Ethinyl Estradiol—CYP2C8—Paclitaxel—ovarian cancer	0.0115	0.026	CbGbCtD
Ethinyl Estradiol—ABCB1—Vinorelbine—ovarian cancer	0.0111	0.0251	CbGbCtD
Ethinyl Estradiol—CYP3A4—Topotecan—ovarian cancer	0.00944	0.0213	CbGbCtD
Ethinyl Estradiol—CYP2B6—Doxorubicin—ovarian cancer	0.0082	0.0185	CbGbCtD
Ethinyl Estradiol—ABCB1—Paclitaxel—ovarian cancer	0.0078	0.0176	CbGbCtD
Ethinyl Estradiol—ESR2—ovarian follicle—ovarian cancer	0.0076	0.142	CbGeAlD
Ethinyl Estradiol—CYP3A4—Vinorelbine—ovarian cancer	0.00665	0.015	CbGbCtD
Ethinyl Estradiol—ABCB1—Docetaxel—ovarian cancer	0.00564	0.0127	CbGbCtD
Ethinyl Estradiol—ESR1—ovarian follicle—ovarian cancer	0.0052	0.0975	CbGeAlD
Ethinyl Estradiol—CYP3A4—Paclitaxel—ovarian cancer	0.00467	0.0105	CbGbCtD
Ethinyl Estradiol—ABCB1—Doxorubicin—ovarian cancer	0.0042	0.00949	CbGbCtD
Ethinyl Estradiol—CYP3A4—Docetaxel—ovarian cancer	0.00338	0.00763	CbGbCtD
Ethinyl Estradiol—ESR2—oviduct—ovarian cancer	0.00334	0.0626	CbGeAlD
Ethinyl Estradiol—CYP3A4—Doxorubicin—ovarian cancer	0.00252	0.00569	CbGbCtD
Ethinyl Estradiol—ESR1—oviduct—ovarian cancer	0.00229	0.0429	CbGeAlD
Ethinyl Estradiol—SLC10A1—gonad—ovarian cancer	0.00104	0.0196	CbGeAlD
Ethinyl Estradiol—AOX1—myometrium—ovarian cancer	0.00103	0.0193	CbGeAlD
Ethinyl Estradiol—SLC10A1—female reproductive system—ovarian cancer	0.000932	0.0175	CbGeAlD
Ethinyl Estradiol—ESR2—epithelium—ovarian cancer	0.000839	0.0157	CbGeAlD
Ethinyl Estradiol—ESR2—uterine cervix—ovarian cancer	0.000831	0.0156	CbGeAlD
Ethinyl Estradiol—AOX1—uterine cervix—ovarian cancer	0.0008	0.015	CbGeAlD
Ethinyl Estradiol—AOX1—decidua—ovarian cancer	0.000762	0.0143	CbGeAlD
Ethinyl Estradiol—SLC10A1—testis—ovarian cancer	0.000752	0.0141	CbGeAlD
Ethinyl Estradiol—ESR2—endometrium—ovarian cancer	0.000752	0.0141	CbGeAlD
Ethinyl Estradiol—ABCB11—testis—ovarian cancer	0.000744	0.0139	CbGeAlD
Ethinyl Estradiol—ESR1—myometrium—ovarian cancer	0.000732	0.0137	CbGeAlD
Ethinyl Estradiol—SHBG—endometrium—ovarian cancer	0.000731	0.0137	CbGeAlD
Ethinyl Estradiol—AOX1—endometrium—ovarian cancer	0.000724	0.0136	CbGeAlD
Ethinyl Estradiol—ESR1—embryo—ovarian cancer	0.000704	0.0132	CbGeAlD
Ethinyl Estradiol—ESR2—gonad—ovarian cancer	0.000697	0.0131	CbGeAlD
Ethinyl Estradiol—ESR2—uterus—ovarian cancer	0.000693	0.013	CbGeAlD
Ethinyl Estradiol—SHBG—gonad—ovarian cancer	0.000678	0.0127	CbGeAlD
Ethinyl Estradiol—SHBG—uterus—ovarian cancer	0.000674	0.0126	CbGeAlD
Ethinyl Estradiol—AOX1—gonad—ovarian cancer	0.000671	0.0126	CbGeAlD
Ethinyl Estradiol—AOX1—uterus—ovarian cancer	0.000667	0.0125	CbGeAlD
Ethinyl Estradiol—ESR2—female reproductive system—ovarian cancer	0.000623	0.0117	CbGeAlD
Ethinyl Estradiol—SHBG—female reproductive system—ovarian cancer	0.000606	0.0113	CbGeAlD
Ethinyl Estradiol—AOX1—female reproductive system—ovarian cancer	0.0006	0.0112	CbGeAlD
Ethinyl Estradiol—ESR1—epithelium—ovarian cancer	0.000574	0.0108	CbGeAlD
Ethinyl Estradiol—SHBG—bone marrow—ovarian cancer	0.000572	0.0107	CbGeAlD
Ethinyl Estradiol—ESR1—uterine cervix—ovarian cancer	0.000569	0.0107	CbGeAlD
Ethinyl Estradiol—ESR2—female gonad—ovarian cancer	0.000567	0.0106	CbGeAlD
Ethinyl Estradiol—ESR2—vagina—ovarian cancer	0.000563	0.0106	CbGeAlD
Ethinyl Estradiol—SHBG—female gonad—ovarian cancer	0.000551	0.0103	CbGeAlD
Ethinyl Estradiol—SHBG—vagina—ovarian cancer	0.000548	0.0103	CbGeAlD
Ethinyl Estradiol—AOX1—female gonad—ovarian cancer	0.000546	0.0102	CbGeAlD
Ethinyl Estradiol—ESR1—decidua—ovarian cancer	0.000543	0.0102	CbGeAlD
Ethinyl Estradiol—AOX1—vagina—ovarian cancer	0.000542	0.0102	CbGeAlD
Ethinyl Estradiol—ESR1—endometrium—ovarian cancer	0.000515	0.00965	CbGeAlD
Ethinyl Estradiol—ESR2—testis—ovarian cancer	0.000503	0.00942	CbGeAlD
Ethinyl Estradiol—SHBG—testis—ovarian cancer	0.000489	0.00916	CbGeAlD
Ethinyl Estradiol—AOX1—testis—ovarian cancer	0.000484	0.00907	CbGeAlD
Ethinyl Estradiol—ESR1—gonad—ovarian cancer	0.000478	0.00895	CbGeAlD
Ethinyl Estradiol—ESR1—uterus—ovarian cancer	0.000475	0.00889	CbGeAlD
Ethinyl Estradiol—ABCC2—female reproductive system—ovarian cancer	0.000469	0.00878	CbGeAlD
Ethinyl Estradiol—Norelgestromin—PGR—ovarian cancer	0.000458	0.09	CrCbGaD
Ethinyl Estradiol—Desogestrel—PGR—ovarian cancer	0.000441	0.0867	CrCbGaD
Ethinyl Estradiol—ESR1—female reproductive system—ovarian cancer	0.000427	0.00799	CbGeAlD
Ethinyl Estradiol—CYP2C8—endometrium—ovarian cancer	0.000424	0.00795	CbGeAlD
Ethinyl Estradiol—ESR1—female gonad—ovarian cancer	0.000388	0.00727	CbGeAlD
Ethinyl Estradiol—ESR1—vagina—ovarian cancer	0.000386	0.00723	CbGeAlD
Ethinyl Estradiol—ABCC2—testis—ovarian cancer	0.000378	0.00709	CbGeAlD
Ethinyl Estradiol—Quinestrol—ESR1—ovarian cancer	0.000372	0.0731	CrCbGaD
Ethinyl Estradiol—ESR2—lymph node—ovarian cancer	0.000364	0.00683	CbGeAlD
Ethinyl Estradiol—Etonogestrel—PGR—ovarian cancer	0.000357	0.0701	CrCbGaD
Ethinyl Estradiol—CYP2B6—gonad—ovarian cancer	0.000353	0.00661	CbGeAlD
Ethinyl Estradiol—CYP2C8—female reproductive system—ovarian cancer	0.000351	0.00659	CbGeAlD
Ethinyl Estradiol—AOX1—lymph node—ovarian cancer	0.000351	0.00657	CbGeAlD
Ethinyl Estradiol—ESR1—testis—ovarian cancer	0.000344	0.00645	CbGeAlD
Ethinyl Estradiol—CYP2C8—vagina—ovarian cancer	0.000318	0.00596	CbGeAlD
Ethinyl Estradiol—CYP2B6—female reproductive system—ovarian cancer	0.000315	0.00591	CbGeAlD
Ethinyl Estradiol—ABCB1—myometrium—ovarian cancer	0.000289	0.00542	CbGeAlD
Ethinyl Estradiol—CYP2B6—vagina—ovarian cancer	0.000285	0.00534	CbGeAlD
Ethinyl Estradiol—CYP2C8—testis—ovarian cancer	0.000284	0.00531	CbGeAlD
Ethinyl Estradiol—Mestranol—ESR1—ovarian cancer	0.000282	0.0554	CrCbGaD
Ethinyl Estradiol—Desogestrel—ESR1—ovarian cancer	0.000278	0.0547	CrCbGaD
Ethinyl Estradiol—ABCB1—embryo—ovarian cancer	0.000278	0.00521	CbGeAlD
Ethinyl Estradiol—ABCC2—lymph node—ovarian cancer	0.000274	0.00514	CbGeAlD
Ethinyl Estradiol—CYP2B6—testis—ovarian cancer	0.000254	0.00477	CbGeAlD
Ethinyl Estradiol—Levonorgestrel—PGR—ovarian cancer	0.000252	0.0496	CrCbGaD
Ethinyl Estradiol—ESR1—lymph node—ovarian cancer	0.00025	0.00468	CbGeAlD
Ethinyl Estradiol—Estriol—ESR1—ovarian cancer	0.000246	0.0483	CrCbGaD
Ethinyl Estradiol—CYP3A4—female reproductive system—ovarian cancer	0.000238	0.00446	CbGeAlD
Ethinyl Estradiol—Danazol—PGR—ovarian cancer	0.00023	0.0452	CrCbGaD
Ethinyl Estradiol—Estramustine—ESR1—ovarian cancer	0.000229	0.0449	CrCbGaD
Ethinyl Estradiol—ABCB1—epithelium—ovarian cancer	0.000227	0.00425	CbGeAlD
Ethinyl Estradiol—Etonogestrel—ESR1—ovarian cancer	0.000225	0.0443	CrCbGaD
Ethinyl Estradiol—ABCB1—uterine cervix—ovarian cancer	0.000225	0.00421	CbGeAlD
Ethinyl Estradiol—ABCB1—decidua—ovarian cancer	0.000214	0.00402	CbGeAlD
Ethinyl Estradiol—Norethindrone—PGR—ovarian cancer	0.000205	0.0402	CrCbGaD
Ethinyl Estradiol—ABCB1—endometrium—ovarian cancer	0.000203	0.00381	CbGeAlD
Ethinyl Estradiol—ABCB1—gonad—ovarian cancer	0.000189	0.00354	CbGeAlD
Ethinyl Estradiol—Estropipate—ESR1—ovarian cancer	0.000188	0.037	CrCbGaD
Ethinyl Estradiol—ABCB1—uterus—ovarian cancer	0.000187	0.00351	CbGeAlD
Ethinyl Estradiol—Estrone—CYP1B1—ovarian cancer	0.000173	0.034	CrCbGaD
Ethinyl Estradiol—ABCB1—female reproductive system—ovarian cancer	0.000169	0.00316	CbGeAlD
Ethinyl Estradiol—Levonorgestrel—ESR1—ovarian cancer	0.000159	0.0313	CrCbGaD
Ethinyl Estradiol—ABCB1—bone marrow—ovarian cancer	0.000159	0.00298	CbGeAlD
Ethinyl Estradiol—ABCB1—female gonad—ovarian cancer	0.000153	0.00287	CbGeAlD
Ethinyl Estradiol—ABCB1—vagina—ovarian cancer	0.000152	0.00286	CbGeAlD
Ethinyl Estradiol—Danazol—ESR1—ovarian cancer	0.000145	0.0285	CrCbGaD
Ethinyl Estradiol—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000145	0.00162	CcSEcCtD
Ethinyl Estradiol—Fatigue—Vinorelbine—ovarian cancer	0.000145	0.00161	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Topotecan—ovarian cancer	0.000144	0.00161	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Paclitaxel—ovarian cancer	0.000144	0.00161	CcSEcCtD
Ethinyl Estradiol—Constipation—Vinorelbine—ovarian cancer	0.000143	0.0016	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Paclitaxel—ovarian cancer	0.000143	0.0016	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Melphalan—ovarian cancer	0.000141	0.00158	CcSEcCtD
Ethinyl Estradiol—Asthenia—Topotecan—ovarian cancer	0.000141	0.00157	CcSEcCtD
Ethinyl Estradiol—Alopecia—Paclitaxel—ovarian cancer	0.00014	0.00157	CcSEcCtD
Ethinyl Estradiol—Hot flush—Epirubicin—ovarian cancer	0.00014	0.00157	CcSEcCtD
Ethinyl Estradiol—Vomiting—Chlorambucil—ovarian cancer	0.00014	0.00156	CcSEcCtD
Ethinyl Estradiol—Increased appetite—Epirubicin—ovarian cancer	0.00014	0.00156	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Paclitaxel—ovarian cancer	0.000139	0.00155	CcSEcCtD
Ethinyl Estradiol—Menopausal symptoms—Epirubicin—ovarian cancer	0.000139	0.00155	CcSEcCtD
Ethinyl Estradiol—Pruritus—Topotecan—ovarian cancer	0.000139	0.00155	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Paclitaxel—ovarian cancer	0.000138	0.00154	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Vinorelbine—ovarian cancer	0.000138	0.00154	CcSEcCtD
Ethinyl Estradiol—Asthenia—Melphalan—ovarian cancer	0.000138	0.00154	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000137	0.00153	CcSEcCtD
Ethinyl Estradiol—ABCB1—testis—ovarian cancer	0.000136	0.00255	CbGeAlD
Ethinyl Estradiol—Pruritus—Melphalan—ovarian cancer	0.000136	0.00152	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Docetaxel—ovarian cancer	0.000135	0.00151	CcSEcCtD
Ethinyl Estradiol—Eczema—Doxorubicin—ovarian cancer	0.000135	0.00151	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Docetaxel—ovarian cancer	0.000135	0.00151	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Docetaxel—ovarian cancer	0.000135	0.0015	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Topotecan—ovarian cancer	0.000134	0.0015	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Docetaxel—ovarian cancer	0.000134	0.00149	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000134	0.00149	CcSEcCtD
Ethinyl Estradiol—Back pain—Paclitaxel—ovarian cancer	0.000134	0.00149	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Docetaxel—ovarian cancer	0.000134	0.00149	CcSEcCtD
Ethinyl Estradiol—Urticaria—Vinorelbine—ovarian cancer	0.000133	0.00149	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Docetaxel—ovarian cancer	0.000133	0.00148	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Paclitaxel—ovarian cancer	0.000133	0.00148	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Vinorelbine—ovarian cancer	0.000133	0.00148	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Vinorelbine—ovarian cancer	0.000133	0.00148	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Docetaxel—ovarian cancer	0.000132	0.00148	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Docetaxel—ovarian cancer	0.000132	0.00147	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Melphalan—ovarian cancer	0.000131	0.00147	CcSEcCtD
Ethinyl Estradiol—Estradiol—CYP1B1—ovarian cancer	0.000131	0.0258	CrCbGaD
Ethinyl Estradiol—Pain in extremity—Epirubicin—ovarian cancer	0.000131	0.00146	CcSEcCtD
Ethinyl Estradiol—Nausea—Chlorambucil—ovarian cancer	0.000131	0.00146	CcSEcCtD
Ethinyl Estradiol—Hot flush—Doxorubicin—ovarian cancer	0.00013	0.00145	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Docetaxel—ovarian cancer	0.00013	0.00145	CcSEcCtD
Ethinyl Estradiol—Dizziness—Topotecan—ovarian cancer	0.00013	0.00145	CcSEcCtD
Ethinyl Estradiol—Increased appetite—Doxorubicin—ovarian cancer	0.000129	0.00144	CcSEcCtD
Ethinyl Estradiol—Affect lability—Epirubicin—ovarian cancer	0.000129	0.00144	CcSEcCtD
Ethinyl Estradiol—Migraine—Epirubicin—ovarian cancer	0.000129	0.00144	CcSEcCtD
Ethinyl Estradiol—Menopausal symptoms—Doxorubicin—ovarian cancer	0.000129	0.00144	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000128	0.00143	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Docetaxel—ovarian cancer	0.000127	0.00142	CcSEcCtD
Ethinyl Estradiol—Angioedema—Paclitaxel—ovarian cancer	0.000126	0.00141	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Docetaxel—ovarian cancer	0.000126	0.0014	CcSEcCtD
Ethinyl Estradiol—Vomiting—Topotecan—ovarian cancer	0.000125	0.00139	CcSEcCtD
Ethinyl Estradiol—Malaise—Paclitaxel—ovarian cancer	0.000125	0.00139	CcSEcCtD
Ethinyl Estradiol—Mood swings—Epirubicin—ovarian cancer	0.000124	0.00139	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000124	0.00138	CcSEcCtD
Ethinyl Estradiol—Rash—Topotecan—ovarian cancer	0.000124	0.00138	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Vinorelbine—ovarian cancer	0.000124	0.00138	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Topotecan—ovarian cancer	0.000123	0.00138	CcSEcCtD
Ethinyl Estradiol—Headache—Topotecan—ovarian cancer	0.000123	0.00137	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Docetaxel—ovarian cancer	0.000122	0.00136	CcSEcCtD
Ethinyl Estradiol—Vomiting—Melphalan—ovarian cancer	0.000122	0.00136	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Docetaxel—ovarian cancer	0.000122	0.00136	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Doxorubicin—ovarian cancer	0.000121	0.00135	CcSEcCtD
Ethinyl Estradiol—Rash—Melphalan—ovarian cancer	0.000121	0.00135	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Melphalan—ovarian cancer	0.000121	0.00135	CcSEcCtD
Ethinyl Estradiol—Cough—Paclitaxel—ovarian cancer	0.000121	0.00135	CcSEcCtD
Ethinyl Estradiol—Asthenia—Vinorelbine—ovarian cancer	0.00012	0.00134	CcSEcCtD
Ethinyl Estradiol—Migraine—Doxorubicin—ovarian cancer	0.000119	0.00133	CcSEcCtD
Ethinyl Estradiol—Affect lability—Doxorubicin—ovarian cancer	0.000119	0.00133	CcSEcCtD
Ethinyl Estradiol—Alopecia—Docetaxel—ovarian cancer	0.000119	0.00133	CcSEcCtD
Ethinyl Estradiol—Pruritus—Vinorelbine—ovarian cancer	0.000119	0.00132	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Epirubicin—ovarian cancer	0.000119	0.00132	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Docetaxel—ovarian cancer	0.000118	0.00132	CcSEcCtD
Ethinyl Estradiol—Conjugated Estrogens—ESR1—ovarian cancer	0.000117	0.0231	CrCbGaD
Ethinyl Estradiol—Anxiety—Paclitaxel—ovarian cancer	0.000117	0.00131	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Docetaxel—ovarian cancer	0.000117	0.00131	CcSEcCtD
Ethinyl Estradiol—Estrone—ESR1—ovarian cancer	0.000117	0.023	CrCbGaD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000117	0.0013	CcSEcCtD
Ethinyl Estradiol—Nausea—Topotecan—ovarian cancer	0.000116	0.0013	CcSEcCtD
Ethinyl Estradiol—Discomfort—Paclitaxel—ovarian cancer	0.000116	0.0013	CcSEcCtD
Ethinyl Estradiol—Mood swings—Doxorubicin—ovarian cancer	0.000115	0.00128	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Vinorelbine—ovarian cancer	0.000115	0.00128	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Epirubicin—ovarian cancer	0.000114	0.00127	CcSEcCtD
Ethinyl Estradiol—Nausea—Melphalan—ovarian cancer	0.000114	0.00127	CcSEcCtD
Ethinyl Estradiol—Back pain—Docetaxel—ovarian cancer	0.000113	0.00126	CcSEcCtD
Ethinyl Estradiol—Oedema—Paclitaxel—ovarian cancer	0.000113	0.00126	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Docetaxel—ovarian cancer	0.000113	0.00126	CcSEcCtD
Ethinyl Estradiol—Infection—Paclitaxel—ovarian cancer	0.000112	0.00125	CcSEcCtD
Ethinyl Estradiol—Dizziness—Vinorelbine—ovarian cancer	0.000111	0.00124	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Paclitaxel—ovarian cancer	0.000111	0.00123	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Doxorubicin—ovarian cancer	0.00011	0.00122	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Paclitaxel—ovarian cancer	0.00011	0.00122	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Epirubicin—ovarian cancer	0.000109	0.00122	CcSEcCtD
Ethinyl Estradiol—Vomiting—Vinorelbine—ovarian cancer	0.000107	0.00119	CcSEcCtD
Ethinyl Estradiol—Dysuria—Epirubicin—ovarian cancer	0.000106	0.00118	CcSEcCtD
Ethinyl Estradiol—Rash—Vinorelbine—ovarian cancer	0.000106	0.00118	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Vinorelbine—ovarian cancer	0.000106	0.00118	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Doxorubicin—ovarian cancer	0.000106	0.00118	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000105	0.00118	CcSEcCtD
Ethinyl Estradiol—Headache—Vinorelbine—ovarian cancer	0.000105	0.00117	CcSEcCtD
Ethinyl Estradiol—Pollakiuria—Epirubicin—ovarian cancer	0.000105	0.00117	CcSEcCtD
Ethinyl Estradiol—Estriol—ABCB1—ovarian cancer	0.000104	0.0205	CrCbGaD
Ethinyl Estradiol—Weight increased—Epirubicin—ovarian cancer	0.000103	0.00115	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Epirubicin—ovarian cancer	0.000103	0.00115	CcSEcCtD
Ethinyl Estradiol—Cough—Docetaxel—ovarian cancer	0.000102	0.00114	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Epirubicin—ovarian cancer	0.000101	0.00113	CcSEcCtD
Ethinyl Estradiol—Infestation—Epirubicin—ovarian cancer	0.000101	0.00113	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Doxorubicin—ovarian cancer	0.000101	0.00113	CcSEcCtD
Ethinyl Estradiol—Nausea—Vinorelbine—ovarian cancer	9.96e-05	0.00111	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Epirubicin—ovarian cancer	9.91e-05	0.00111	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	9.9e-05	0.00111	CcSEcCtD
Ethinyl Estradiol—ABCB1—lymph node—ovarian cancer	9.86e-05	0.00185	CbGeAlD
Ethinyl Estradiol—Urinary tract infection—Epirubicin—ovarian cancer	9.83e-05	0.0011	CcSEcCtD
Ethinyl Estradiol—Dysuria—Doxorubicin—ovarian cancer	9.81e-05	0.0011	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Doxorubicin—ovarian cancer	9.75e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	9.74e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—Fatigue—Paclitaxel—ovarian cancer	9.72e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—Estramustine—ABCB1—ovarian cancer	9.71e-05	0.0191	CrCbGaD
Ethinyl Estradiol—Pollakiuria—Doxorubicin—ovarian cancer	9.69e-05	0.00108	CcSEcCtD
Ethinyl Estradiol—Constipation—Paclitaxel—ovarian cancer	9.64e-05	0.00108	CcSEcCtD
Ethinyl Estradiol—Oedema—Docetaxel—ovarian cancer	9.56e-05	0.00107	CcSEcCtD
Ethinyl Estradiol—Weight increased—Doxorubicin—ovarian cancer	9.55e-05	0.00107	CcSEcCtD
Ethinyl Estradiol—Infection—Docetaxel—ovarian cancer	9.5e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Doxorubicin—ovarian cancer	9.49e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Epirubicin—ovarian cancer	9.49e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Docetaxel—ovarian cancer	9.38e-05	0.00105	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Doxorubicin—ovarian cancer	9.35e-05	0.00104	CcSEcCtD
Ethinyl Estradiol—Infestation—Doxorubicin—ovarian cancer	9.35e-05	0.00104	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Paclitaxel—ovarian cancer	9.29e-05	0.00104	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Docetaxel—ovarian cancer	9.29e-05	0.00104	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Paclitaxel—ovarian cancer	9.22e-05	0.00103	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Doxorubicin—ovarian cancer	9.17e-05	0.00102	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Epirubicin—ovarian cancer	9.12e-05	0.00102	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Epirubicin—ovarian cancer	9.1e-05	0.00102	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Doxorubicin—ovarian cancer	9.09e-05	0.00101	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Epirubicin—ovarian cancer	9.08e-05	0.00101	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Epirubicin—ovarian cancer	9.03e-05	0.00101	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Epirubicin—ovarian cancer	9.01e-05	0.00101	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Epirubicin—ovarian cancer	8.96e-05	0.001	CcSEcCtD
Ethinyl Estradiol—Urticaria—Paclitaxel—ovarian cancer	8.96e-05	0.001	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Epirubicin—ovarian cancer	8.92e-05	0.000996	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Paclitaxel—ovarian cancer	8.92e-05	0.000995	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Paclitaxel—ovarian cancer	8.92e-05	0.000995	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Epirubicin—ovarian cancer	8.9e-05	0.000993	CcSEcCtD
Ethinyl Estradiol—Estradiol—ESR1—ovarian cancer	8.87e-05	0.0174	CrCbGaD
Ethinyl Estradiol—Sinusitis—Doxorubicin—ovarian cancer	8.78e-05	0.00098	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Epirubicin—ovarian cancer	8.75e-05	0.000976	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Epirubicin—ovarian cancer	8.58e-05	0.000958	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Epirubicin—ovarian cancer	8.48e-05	0.000947	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Doxorubicin—ovarian cancer	8.44e-05	0.000942	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Doxorubicin—ovarian cancer	8.42e-05	0.00094	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Doxorubicin—ovarian cancer	8.4e-05	0.000937	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Doxorubicin—ovarian cancer	8.36e-05	0.000933	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Doxorubicin—ovarian cancer	8.33e-05	0.00093	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Paclitaxel—ovarian cancer	8.31e-05	0.000928	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Doxorubicin—ovarian cancer	8.29e-05	0.000926	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Docetaxel—ovarian cancer	8.25e-05	0.000921	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Doxorubicin—ovarian cancer	8.25e-05	0.000921	CcSEcCtD
Ethinyl Estradiol—Fatigue—Docetaxel—ovarian cancer	8.24e-05	0.00092	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Epirubicin—ovarian cancer	8.23e-05	0.000919	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Doxorubicin—ovarian cancer	8.23e-05	0.000919	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Epirubicin—ovarian cancer	8.2e-05	0.000915	CcSEcCtD
Ethinyl Estradiol—Constipation—Docetaxel—ovarian cancer	8.18e-05	0.000912	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Doxorubicin—ovarian cancer	8.09e-05	0.000903	CcSEcCtD
Ethinyl Estradiol—Asthenia—Paclitaxel—ovarian cancer	8.09e-05	0.000903	CcSEcCtD
Ethinyl Estradiol—Alopecia—Epirubicin—ovarian cancer	8.02e-05	0.000895	CcSEcCtD
Ethinyl Estradiol—Pruritus—Paclitaxel—ovarian cancer	7.98e-05	0.000891	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Epirubicin—ovarian cancer	7.95e-05	0.000888	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Doxorubicin—ovarian cancer	7.94e-05	0.000886	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Epirubicin—ovarian cancer	7.9e-05	0.000882	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Docetaxel—ovarian cancer	7.88e-05	0.000879	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Doxorubicin—ovarian cancer	7.85e-05	0.000876	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Docetaxel—ovarian cancer	7.82e-05	0.000873	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Paclitaxel—ovarian cancer	7.72e-05	0.000861	CcSEcCtD
Ethinyl Estradiol—Back pain—Epirubicin—ovarian cancer	7.64e-05	0.000853	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Doxorubicin—ovarian cancer	7.62e-05	0.00085	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Epirubicin—ovarian cancer	7.6e-05	0.000848	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Doxorubicin—ovarian cancer	7.59e-05	0.000847	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Docetaxel—ovarian cancer	7.56e-05	0.000844	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Docetaxel—ovarian cancer	7.56e-05	0.000844	CcSEcCtD
Ethinyl Estradiol—Dizziness—Paclitaxel—ovarian cancer	7.46e-05	0.000832	CcSEcCtD
Ethinyl Estradiol—Alopecia—Doxorubicin—ovarian cancer	7.42e-05	0.000828	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Doxorubicin—ovarian cancer	7.36e-05	0.000821	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Epirubicin—ovarian cancer	7.33e-05	0.000818	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Doxorubicin—ovarian cancer	7.31e-05	0.000816	CcSEcCtD
Ethinyl Estradiol—Vomiting—Paclitaxel—ovarian cancer	7.17e-05	0.0008	CcSEcCtD
Ethinyl Estradiol—Malaise—Epirubicin—ovarian cancer	7.12e-05	0.000795	CcSEcCtD
Ethinyl Estradiol—Rash—Paclitaxel—ovarian cancer	7.11e-05	0.000794	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Paclitaxel—ovarian cancer	7.1e-05	0.000793	CcSEcCtD
Ethinyl Estradiol—Back pain—Doxorubicin—ovarian cancer	7.07e-05	0.000789	CcSEcCtD
Ethinyl Estradiol—Headache—Paclitaxel—ovarian cancer	7.07e-05	0.000789	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Docetaxel—ovarian cancer	7.04e-05	0.000786	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Doxorubicin—ovarian cancer	7.03e-05	0.000785	CcSEcCtD
Ethinyl Estradiol—Cough—Epirubicin—ovarian cancer	6.89e-05	0.00077	CcSEcCtD
Ethinyl Estradiol—Asthenia—Docetaxel—ovarian cancer	6.86e-05	0.000766	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Doxorubicin—ovarian cancer	6.78e-05	0.000757	CcSEcCtD
Ethinyl Estradiol—Pruritus—Docetaxel—ovarian cancer	6.76e-05	0.000755	CcSEcCtD
Ethinyl Estradiol—Anxiety—Epirubicin—ovarian cancer	6.7e-05	0.000748	CcSEcCtD
Ethinyl Estradiol—Nausea—Paclitaxel—ovarian cancer	6.7e-05	0.000748	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	6.68e-05	0.000746	CcSEcCtD
Ethinyl Estradiol—Discomfort—Epirubicin—ovarian cancer	6.65e-05	0.000742	CcSEcCtD
Ethinyl Estradiol—Malaise—Doxorubicin—ovarian cancer	6.59e-05	0.000736	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Docetaxel—ovarian cancer	6.54e-05	0.00073	CcSEcCtD
Ethinyl Estradiol—Oedema—Epirubicin—ovarian cancer	6.45e-05	0.00072	CcSEcCtD
Ethinyl Estradiol—Infection—Epirubicin—ovarian cancer	6.41e-05	0.000715	CcSEcCtD
Ethinyl Estradiol—Cough—Doxorubicin—ovarian cancer	6.38e-05	0.000712	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Epirubicin—ovarian cancer	6.32e-05	0.000706	CcSEcCtD
Ethinyl Estradiol—Dizziness—Docetaxel—ovarian cancer	6.32e-05	0.000706	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Epirubicin—ovarian cancer	6.26e-05	0.000699	CcSEcCtD
Ethinyl Estradiol—Anxiety—Doxorubicin—ovarian cancer	6.2e-05	0.000692	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	6.18e-05	0.00069	CcSEcCtD
Ethinyl Estradiol—Discomfort—Doxorubicin—ovarian cancer	6.15e-05	0.000686	CcSEcCtD
Ethinyl Estradiol—Vomiting—Docetaxel—ovarian cancer	6.08e-05	0.000678	CcSEcCtD
Ethinyl Estradiol—Rash—Docetaxel—ovarian cancer	6.03e-05	0.000673	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Docetaxel—ovarian cancer	6.02e-05	0.000672	CcSEcCtD
Ethinyl Estradiol—Headache—Docetaxel—ovarian cancer	5.99e-05	0.000668	CcSEcCtD
Ethinyl Estradiol—Oedema—Doxorubicin—ovarian cancer	5.97e-05	0.000666	CcSEcCtD
Ethinyl Estradiol—Infection—Doxorubicin—ovarian cancer	5.93e-05	0.000662	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Doxorubicin—ovarian cancer	5.85e-05	0.000653	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Doxorubicin—ovarian cancer	5.8e-05	0.000647	CcSEcCtD
Ethinyl Estradiol—Nausea—Docetaxel—ovarian cancer	5.68e-05	0.000634	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Epirubicin—ovarian cancer	5.57e-05	0.000621	CcSEcCtD
Ethinyl Estradiol—Fatigue—Epirubicin—ovarian cancer	5.56e-05	0.000621	CcSEcCtD
Ethinyl Estradiol—Constipation—Epirubicin—ovarian cancer	5.51e-05	0.000615	CcSEcCtD
Ethinyl Estradiol—Norethindrone—ABCB1—ovarian cancer	5.49e-05	0.0108	CrCbGaD
Ethinyl Estradiol—Feeling abnormal—Epirubicin—ovarian cancer	5.31e-05	0.000593	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Epirubicin—ovarian cancer	5.27e-05	0.000589	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	5.15e-05	0.000575	CcSEcCtD
Ethinyl Estradiol—Fatigue—Doxorubicin—ovarian cancer	5.14e-05	0.000574	CcSEcCtD
Ethinyl Estradiol—Urticaria—Epirubicin—ovarian cancer	5.12e-05	0.000572	CcSEcCtD
Ethinyl Estradiol—Constipation—Doxorubicin—ovarian cancer	5.1e-05	0.000569	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Epirubicin—ovarian cancer	5.1e-05	0.000569	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Epirubicin—ovarian cancer	5.1e-05	0.000569	CcSEcCtD
Ethinyl Estradiol—Conjugated Estrogens—ABCB1—ovarian cancer	4.98e-05	0.0098	CrCbGaD
Ethinyl Estradiol—Estrone—ABCB1—ovarian cancer	4.97e-05	0.00977	CrCbGaD
Ethinyl Estradiol—Feeling abnormal—Doxorubicin—ovarian cancer	4.92e-05	0.000549	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Doxorubicin—ovarian cancer	4.88e-05	0.000545	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Epirubicin—ovarian cancer	4.75e-05	0.00053	CcSEcCtD
Ethinyl Estradiol—Urticaria—Doxorubicin—ovarian cancer	4.74e-05	0.000529	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Doxorubicin—ovarian cancer	4.72e-05	0.000526	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Doxorubicin—ovarian cancer	4.72e-05	0.000526	CcSEcCtD
Ethinyl Estradiol—Asthenia—Epirubicin—ovarian cancer	4.63e-05	0.000516	CcSEcCtD
Ethinyl Estradiol—Pruritus—Epirubicin—ovarian cancer	4.56e-05	0.000509	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Epirubicin—ovarian cancer	4.41e-05	0.000492	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Doxorubicin—ovarian cancer	4.4e-05	0.000491	CcSEcCtD
Ethinyl Estradiol—Asthenia—Doxorubicin—ovarian cancer	4.28e-05	0.000478	CcSEcCtD
Ethinyl Estradiol—Dizziness—Epirubicin—ovarian cancer	4.26e-05	0.000476	CcSEcCtD
Ethinyl Estradiol—Pruritus—Doxorubicin—ovarian cancer	4.22e-05	0.000471	CcSEcCtD
Ethinyl Estradiol—Vomiting—Epirubicin—ovarian cancer	4.1e-05	0.000458	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Doxorubicin—ovarian cancer	4.08e-05	0.000456	CcSEcCtD
Ethinyl Estradiol—Rash—Epirubicin—ovarian cancer	4.07e-05	0.000454	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Epirubicin—ovarian cancer	4.06e-05	0.000453	CcSEcCtD
Ethinyl Estradiol—Headache—Epirubicin—ovarian cancer	4.04e-05	0.000451	CcSEcCtD
Ethinyl Estradiol—Dizziness—Doxorubicin—ovarian cancer	3.95e-05	0.00044	CcSEcCtD
Ethinyl Estradiol—Nausea—Epirubicin—ovarian cancer	3.83e-05	0.000428	CcSEcCtD
Ethinyl Estradiol—Vomiting—Doxorubicin—ovarian cancer	3.79e-05	0.000423	CcSEcCtD
Ethinyl Estradiol—Estradiol—ABCB1—ovarian cancer	3.77e-05	0.0074	CrCbGaD
Ethinyl Estradiol—Rash—Doxorubicin—ovarian cancer	3.76e-05	0.00042	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Doxorubicin—ovarian cancer	3.76e-05	0.00042	CcSEcCtD
Ethinyl Estradiol—Headache—Doxorubicin—ovarian cancer	3.74e-05	0.000417	CcSEcCtD
Ethinyl Estradiol—Nausea—Doxorubicin—ovarian cancer	3.54e-05	0.000396	CcSEcCtD
Ethinyl Estradiol—CYP2C8—Metabolism—NME2—ovarian cancer	2.4e-05	0.000462	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—CYP1B1—ovarian cancer	2.4e-05	0.000461	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	2.35e-05	0.000452	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	2.34e-05	0.000451	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	2.3e-05	0.000442	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	2.3e-05	0.000442	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—ABCB1—ovarian cancer	2.29e-05	0.000441	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—MAPK1—ovarian cancer	2.29e-05	0.00044	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—EGFR—ovarian cancer	2.29e-05	0.00044	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	2.27e-05	0.000436	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—TYMS—ovarian cancer	2.25e-05	0.000433	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—YAP1—ovarian cancer	2.21e-05	0.000425	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.19e-05	0.000422	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.19e-05	0.000421	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	2.17e-05	0.000418	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—KRAS—ovarian cancer	2.16e-05	0.000415	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PPP2R1A—ovarian cancer	2.12e-05	0.000408	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	2.12e-05	0.000407	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	2.11e-05	0.000406	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—NME2—ovarian cancer	2.09e-05	0.000402	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	2.08e-05	0.000401	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.04e-05	0.000392	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.03e-05	0.00039	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—TERT—ovarian cancer	2.02e-05	0.000387	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2e-05	0.000385	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—PIK3CA—ovarian cancer	1.99e-05	0.000382	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	1.98e-05	0.000381	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—DOK1—ovarian cancer	1.98e-05	0.000381	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—ABCB1—ovarian cancer	1.97e-05	0.000379	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.95e-05	0.000374	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—TYMS—ovarian cancer	1.94e-05	0.000372	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	1.93e-05	0.000371	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.92e-05	0.00037	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—YAP1—ovarian cancer	1.92e-05	0.000369	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Generic Transcription Pathway—MYC—ovarian cancer	1.92e-05	0.000369	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.91e-05	0.000366	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.91e-05	0.000366	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	1.87e-05	0.00036	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CAV1—ovarian cancer	1.86e-05	0.000358	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PPP1CC—ovarian cancer	1.86e-05	0.000358	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—HRAS—ovarian cancer	1.84e-05	0.000353	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYTB—ovarian cancer	1.83e-05	0.000351	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—CAV1—ovarian cancer	1.82e-05	0.000349	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—FASN—ovarian cancer	1.8e-05	0.000347	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.8e-05	0.000346	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—ESR1—ovarian cancer	1.78e-05	0.000341	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—SLC5A5—ovarian cancer	1.77e-05	0.000341	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—IL6ST—ovarian cancer	1.77e-05	0.00034	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—IL6—ovarian cancer	1.76e-05	0.000338	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.73e-05	0.000333	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—SLC2A1—ovarian cancer	1.71e-05	0.000329	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—APC—ovarian cancer	1.7e-05	0.000326	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PGR—ovarian cancer	1.68e-05	0.000322	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.68e-05	0.000322	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.67e-05	0.000322	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.66e-05	0.000319	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PIK3CG—ovarian cancer	1.65e-05	0.000318	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.65e-05	0.000318	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—CYP1B1—ovarian cancer	1.64e-05	0.000316	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	1.63e-05	0.000313	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—AKT1—ovarian cancer	1.62e-05	0.000312	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.6e-05	0.000308	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—BRIP1—ovarian cancer	1.6e-05	0.000307	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PPP1CC—ovarian cancer	1.6e-05	0.000307	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—CAV1—ovarian cancer	1.56e-05	0.0003	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PARP1—ovarian cancer	1.56e-05	0.0003	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYTB—ovarian cancer	1.55e-05	0.000297	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.51e-05	0.000291	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PIK3CD—ovarian cancer	1.49e-05	0.000287	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PPP2R1A—ovarian cancer	1.46e-05	0.00028	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.45e-05	0.00028	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PIK3CD—ovarian cancer	1.45e-05	0.000279	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.45e-05	0.000279	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PIK3CG—ovarian cancer	1.42e-05	0.000273	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—HDAC6—ovarian cancer	1.41e-05	0.000271	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.35e-05	0.00026	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.35e-05	0.00026	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.35e-05	0.00026	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—ABCB1—ovarian cancer	1.35e-05	0.00026	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.35e-05	0.00026	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—MAPK3—ovarian cancer	1.35e-05	0.00026	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYTB—ovarian cancer	1.35e-05	0.000259	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.35e-05	0.000259	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—TYMS—ovarian cancer	1.33e-05	0.000255	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.32e-05	0.000254	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—ERBB2—ovarian cancer	1.32e-05	0.000253	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—MYC—ovarian cancer	1.31e-05	0.000252	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.31e-05	0.000251	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PIK3CB—ovarian cancer	1.3e-05	0.00025	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MTOR—ovarian cancer	1.3e-05	0.00025	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—NME2—ovarian cancer	1.29e-05	0.000248	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.28e-05	0.000247	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.27e-05	0.000245	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PIK3CB—ovarian cancer	1.27e-05	0.000244	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PPP2R1A—ovarian cancer	1.26e-05	0.000243	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PIK3CD—ovarian cancer	1.25e-05	0.00024	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—YAP1—ovarian cancer	1.25e-05	0.00024	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.24e-05	0.000238	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—XIAP—ovarian cancer	1.22e-05	0.000235	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CDKN1B—ovarian cancer	1.22e-05	0.000235	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—SMARCA4—ovarian cancer	1.19e-05	0.000229	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.18e-05	0.000227	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—BRIP1—ovarian cancer	1.18e-05	0.000227	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—EREG—ovarian cancer	1.16e-05	0.000224	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CTNNB1—ovarian cancer	1.15e-05	0.000222	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PTEN—ovarian cancer	1.12e-05	0.000216	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.12e-05	0.000215	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PTEN—ovarian cancer	1.09e-05	0.000211	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PGR—ovarian cancer	1.09e-05	0.00021	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PIK3CB—ovarian cancer	1.09e-05	0.000209	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—YAP1—ovarian cancer	1.07e-05	0.000206	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—CAV1—ovarian cancer	1.07e-05	0.000206	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.06e-05	0.000204	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.03e-05	0.000198	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.02e-05	0.000197	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PARP1—ovarian cancer	1.01e-05	0.000195	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.01e-05	0.000194	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.01e-05	0.000194	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—STAT3—ovarian cancer	1.01e-05	0.000193	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—NRAS—ovarian cancer	1e-05	0.000193	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.86e-06	0.000189	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PIK3CG—ovarian cancer	9.75e-06	0.000187	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—MYC—ovarian cancer	9.68e-06	0.000186	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MAPK3—ovarian cancer	9.61e-06	0.000185	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	9.52e-06	0.000183	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—MAPK3—ovarian cancer	9.5e-06	0.000183	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PTEN—ovarian cancer	9.42e-06	0.000181	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MYC—ovarian cancer	9.34e-06	0.00018	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—MYC—ovarian cancer	9.24e-06	0.000178	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MAPK1—ovarian cancer	9.14e-06	0.000176	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—EGFR—ovarian cancer	9.14e-06	0.000176	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—AKT1—ovarian cancer	9.11e-06	0.000175	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—YAP1—ovarian cancer	9.07e-06	0.000174	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.98e-06	0.000173	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	8.75e-06	0.000168	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—FASN—ovarian cancer	8.74e-06	0.000168	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—KRAS—ovarian cancer	8.63e-06	0.000166	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—SLC5A5—ovarian cancer	8.59e-06	0.000165	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PIK3CD—ovarian cancer	8.57e-06	0.000165	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.46e-06	0.000163	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYTB—ovarian cancer	8.31e-06	0.00016	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—SLC2A1—ovarian cancer	8.3e-06	0.00016	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PPP2R1A—ovarian cancer	8.22e-06	0.000158	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYP1B1—ovarian cancer	7.96e-06	0.000153	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PIK3CA—ovarian cancer	7.93e-06	0.000152	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—YAP1—ovarian cancer	7.9e-06	0.000152	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.89e-06	0.000152	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PIK3CA—ovarian cancer	7.72e-06	0.000149	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PIK3CB—ovarian cancer	7.47e-06	0.000144	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—FASN—ovarian cancer	7.4e-06	0.000142	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—HRAS—ovarian cancer	7.34e-06	0.000141	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—SLC5A5—ovarian cancer	7.27e-06	0.00014	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.26e-06	0.00014	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.26e-06	0.00014	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.15e-06	0.000137	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	7.06e-06	0.000136	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—SLC2A1—ovarian cancer	7.03e-06	0.000135	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—IL6—ovarian cancer	7.02e-06	0.000135	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.88e-06	0.000132	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYP1B1—ovarian cancer	6.74e-06	0.000129	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PIK3CA—ovarian cancer	6.64e-06	0.000128	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ABCB1—ovarian cancer	6.55e-06	0.000126	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TERT—ovarian cancer	6.53e-06	0.000126	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—AKT1—ovarian cancer	6.48e-06	0.000125	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PTEN—ovarian cancer	6.45e-06	0.000124	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—FASN—ovarian cancer	6.44e-06	0.000124	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—TYMS—ovarian cancer	6.43e-06	0.000124	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—AKT1—ovarian cancer	6.41e-06	0.000123	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.34e-06	0.000122	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—AKT1—ovarian cancer	6.31e-06	0.000121	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.12e-06	0.000118	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CAV1—ovarian cancer	6.04e-06	0.000116	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	5.97e-06	0.000115	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.94e-06	0.000114	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP1B1—ovarian cancer	5.87e-06	0.000113	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IL6ST—ovarian cancer	5.73e-06	0.00011	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ABCB1—ovarian cancer	5.55e-06	0.000107	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PIK3CG—ovarian cancer	5.51e-06	0.000106	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—APC—ovarian cancer	5.51e-06	0.000106	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—TYMS—ovarian cancer	5.45e-06	0.000105	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—AKT1—ovarian cancer	5.43e-06	0.000104	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.2e-06	0.0001	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CAV1—ovarian cancer	5.18e-06	9.97e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—YAP1—ovarian cancer	4.87e-06	9.36e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PIK3CD—ovarian cancer	4.84e-06	9.3e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—MAPK3—ovarian cancer	4.79e-06	9.21e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—TYMS—ovarian cancer	4.75e-06	9.12e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PIK3CG—ovarian cancer	4.72e-06	9.08e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—MYC—ovarian cancer	4.66e-06	8.96e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PIK3CA—ovarian cancer	4.55e-06	8.75e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CAV1—ovarian cancer	4.39e-06	8.44e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—ERBB2—ovarian cancer	4.27e-06	8.22e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MTOR—ovarian cancer	4.22e-06	8.11e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PIK3CB—ovarian cancer	4.22e-06	8.11e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.19e-06	8.06e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PIK3CD—ovarian cancer	4.15e-06	7.98e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CXCL8—ovarian cancer	4.05e-06	7.79e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PIK3CG—ovarian cancer	4e-06	7.69e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—FASN—ovarian cancer	3.97e-06	7.63e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CDKN1B—ovarian cancer	3.96e-06	7.61e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.9e-06	7.51e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CASP3—ovarian cancer	3.88e-06	7.46e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IL2—ovarian cancer	3.87e-06	7.45e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CAV1—ovarian cancer	3.82e-06	7.35e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCND1—ovarian cancer	3.78e-06	7.26e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.77e-06	7.25e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CTNNB1—ovarian cancer	3.74e-06	7.19e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—AKT1—ovarian cancer	3.72e-06	7.15e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MMP9—ovarian cancer	3.67e-06	7.05e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PTEN—ovarian cancer	3.65e-06	7.01e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PIK3CB—ovarian cancer	3.62e-06	6.96e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.62e-06	6.95e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PIK3CD—ovarian cancer	3.51e-06	6.76e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.48e-06	6.7e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—VEGFA—ovarian cancer	3.29e-06	6.33e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—STAT3—ovarian cancer	3.26e-06	6.27e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NRAS—ovarian cancer	3.25e-06	6.25e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—AKT1—ovarian cancer	3.23e-06	6.21e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.21e-06	6.16e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PTEN—ovarian cancer	3.13e-06	6.01e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MAPK3—ovarian cancer	3.11e-06	5.99e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.06e-06	5.89e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.06e-06	5.89e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MYC—ovarian cancer	3.03e-06	5.82e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.98e-06	5.72e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MAPK1—ovarian cancer	2.96e-06	5.7e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—EGFR—ovarian cancer	2.96e-06	5.7e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—TYMS—ovarian cancer	2.92e-06	5.62e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KRAS—ovarian cancer	2.8e-06	5.38e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.67e-06	5.13e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PTEN—ovarian cancer	2.65e-06	5.09e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PIK3CA—ovarian cancer	2.57e-06	4.94e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TP53—ovarian cancer	2.49e-06	4.78e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—HRAS—ovarian cancer	2.38e-06	4.57e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CAV1—ovarian cancer	2.36e-06	4.53e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PTEN—ovarian cancer	2.31e-06	4.43e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IL6—ovarian cancer	2.28e-06	4.38e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PIK3CA—ovarian cancer	2.21e-06	4.24e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.15e-06	4.13e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—AKT1—ovarian cancer	2.1e-06	4.04e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.89e-06	3.63e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.87e-06	3.59e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—AKT1—ovarian cancer	1.8e-06	3.46e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.64e-06	3.16e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.63e-06	3.13e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—AKT1—ovarian cancer	1.53e-06	2.93e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PTEN—ovarian cancer	1.42e-06	2.73e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—AKT1—ovarian cancer	1.33e-06	2.56e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1e-06	1.93e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—AKT1—ovarian cancer	8.19e-07	1.57e-05	CbGpPWpGaD
